Position
BRAIDWELL LP in Fulcrum Therapeutics, Inc.
Back to the book · All holders of FULC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$11.1M$11.31 → $7.67
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 3.06M | $34.6M | — | — | — | 1.1% |
| Q1 2026 | 3.13M | $24M | $7.67 | −$11.1M | $565.3K | 0.8% |